ScreenerHero

PBH Prestige Consumer Healthcare Inc. Common Stock

NYSE · US · Healthcare · Drug Manufacturers - Specialty & Generic · prestigebrands.com
45.01USD-0.54%Mkt Cap: 2.14B $P/E: 12.68

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and interna…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap2.14B USD
Enterprise Value4.12B USD
Revenue (TTM)1.10B USD
Gross Profit595.58M USD
Net Income (TTM)190.30M USD
Revenue/Share23.04 USD
Last Price45.01 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees890
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.68
P/E (Forward)8.91
PEG1.43
EV/EBITDA12.67
EV/Revenue3.73
P/S1.94
P/B1.12
EPS (TTM)3.57
EPS (Forward)5.08
52W Range
42.628% of range71.07
52W High71.07 USD
52W Low42.62 USD
Profitability
Gross Margin54.71%
Oper. Margin20.83%
EBITDA Margin29.45%
Profit Margin17.48%
ROE10.08%
ROA5.45%
Growth
Revenue Growth6.50%
Earnings Growth-35.80%
Cash Flow & Leverage
Operating CF257.63M USD
CapEx (TTM)11.18M USD
FCF Margin13.38%
FCF Yield6.90%
Net Debt1.98B USD
Net Debt/EBITDA6.08
Balance Sheet
Debt/Equity0.55
Current Ratio3.23
Quick Ratio1.80
Book Value/Sh40.46 USD
Cash/Share1.88 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)67.80 USD
Upside (mean)+50.6%
Target Range55.00 USD – 75.00 USD
55.00+50.6% to mean75.00
# Analysts5
Ownership
Shares Out.47.37M
Float46.70M
Insiders1.41%
Institutions116.29%
Short Interest
Short Ratio10.4d
Short % Float12.21%
Short % Out.10.12%
Shares Short4.79M
Short (prev mo.)4.27M
Technical
SMA 5049.90 (-9.8%)
SMA 20055.55 (-19.0%)
Beta0.33
S&P 52W Chg14.58%
Avg Vol (30d)545.25K
Avg Vol (10d)594.70K
Technical Indicators
RSI (14)38.8
MACD-1.2821
MACD Signal-1.2197
MACD Hist.-0.0624
BB Upper50.44 USD
BB Middle47.00 USD
BB Lower43.55 USD
BB Width14.67%
ATR (14)1.474 USD
Vol Ratio (20d)0.87x